Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The market for arteriotomy closure devices has been experiencing significant growth recently, driven by technological advances and increasing medical needs. As healthcare evolves, these devices are becoming more critical in improving patient outcomes during cardiovascular procedures. Below, we explore the current market size, key growth factors, segmentation, emerging trends, major players, and regional dynamics shaping this industry’s future.

Arteriotomy Closure Devices Market Size and Growth Outlook

The arteriotomy closure devices market has demonstrated strong expansion over recent years. It is projected to grow from $1.72 billion in 2025 to $1.84 billion in 2026, representing a compound annual growth rate (CAGR) of 6.9%. This growth during the historical period is primarily fueled by an increased number of catheter-based interventions, broader adoption of minimally invasive angiography techniques, rising rates of cardiovascular diseases, enhanced clinical acceptance of closure devices, and the expansion of interventional cardiology services. Looking ahead, the market is expected to continue its upward trajectory, reaching $2.38 billion by 2030 at a CAGR of 6.7%. Key factors supporting this forecast include a rising demand for next-generation vascular closure systems, a growing focus on minimizing procedure-related complications, increasing outpatient vascular procedures, investments in bioresorbable materials, and wider adoption of advanced closure technologies. Notable trends shaping the future of this market include greater use of suture-based closure devices, preference for radial access closure solutions, enhanced utilization of bioabsorbable hemostatic materials, growth in minimally invasive vascular procedures, and an emphasis on accelerating patient recovery.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20712&type=smp

Cardiovascular Disease Trends Fueling Demand for Arteriotomy Closure Devices

A primary driver propelling the arteriotomy closure devices market is the increasing prevalence of cardiovascular diseases (CVDs). These disorders, which impact the heart and blood vessels, are becoming more widespread due to lifestyle factors such as poor diets, physical inactivity, obesity, and an aging global population. Arteriotomy closure devices play a crucial role in cardiovascular treatments by quickly and securely sealing arterial puncture sites, which helps reduce complications and speeds up recovery following interventions like angioplasties and catheterizations.

To illustrate, in September 2024, the British Heart Foundation, a UK-based cardiovascular research charity, reported that around 7.6 million people in the UK are currently affected by heart and circulatory diseases, including 4 million men and 3.6 million women. Projections suggest this number could increase by 1 million by 2030 and possibly rise by 2 million more by 2040. This rising patient population directly contributes to expanding demand in the arteriotomy closure devices market.

Detailed Segmentation of the Arteriotomy Closure Devices Market

This market is categorized into several segments to better understand revenue opportunities and product focus.

By Product Type:

– Active Closure Devices

– Passive Closure Devices

By Application:

– Femoral Arterial Access Procedures

– Radial Arterial Access Procedures

By End User:

– Hospitals

– Ambulatory Care Centers

– Other End Users

https://www.thebusinessresearchcompany.com/report/arteriotomy-closure-devices-global-market-report

Arteriotomy Closure Devices Market Global Footprint: Which Region Holds Market Leadership?

Further subcategories include:

Active Closure Devices, which comprise suture-based devices, staple-based devices, vascular closure devices containing collagen or hemostatic agents, and balloon-based devices.

Passive Closure Devices include compression devices, hemostatic patches or sponges, and vascular plugs.

Innovations and Technological Advancements Shaping Market Trends

Leading companies within the arteriotomy closure devices market are prioritizing innovation to increase procedural efficiency, improve clinical outcomes, and respond to the growing preference for minimally invasive vascular access solutions. One notable advancement is the development of mid-bore venous closure devices, designed to seal venous access points created by medium-sized catheters or sheaths, supporting hemostasis and faster patient recovery after interventions.

For example, in June 2024, Haemonetics Corp, a US-based healthcare firm, expanded its VASCADE product line by introducing the VASCADE MVP XL mid-bore venous closure device. This new device is tailored for larger sheaths (10-12F, up to 15F outer diameter) used in procedures such as cryoablation. It features 58% more collagen and a larger collapsible disc to achieve rapid hemostasis. This addition complements Haemonetics’ offerings of small- and mid-bore vascular closure solutions, underscoring the company’s leadership in advanced closure technologies.

Key Players Driving the Arteriotomy Closure Devices Market Forward

Several prominent companies are shaping the direction of this market, including:

Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Terumo Corporation, Teleflex Incorporated, Cook Medical Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Haemonetics Corporation, Cordis Corporation, Asahi Intecc Co. Ltd., LeMaitre Vascular Inc., Cardiva Medical Inc., AccessClosure Inc., Vasorum Limited, Invamed (Pty) Ltd., Artio Medical Inc., SUTUREGARD Medical Inc., and Vivasure Medical.

Geographical Market Outlook Highlighting Regional Leadership

In 2025, North America was the leading market for arteriotomy closure devices, holding the largest share globally. However, the Asia-Pacific region is expected to experience the fastest growth during the forecast period. The market analysis includes key regions such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of worldwide market trends and expansion opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model